MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7759/cureus.95128

Медицинская библиотека · Cureus · 2025

Optimizing Transarterial Chemoembolization in Hepatocellular Carcinoma: Current Strategies, Innovations, and Future Directions.

Dolphin Jeraun, Zubillaga Juan, Jamal Qazi Muhammad, Edakkattu Afrah Fathima Karimbanakkal, Balakrishnan Bhavana, Sapkota Aarati, Naimat Anum, Nyein Aye, Okorie Confidence Obianuju, Mahmood Ahmad, Dev Aabind S

СтатьяОбзорПеревод в очереди

Аннотация

Hepatocellular carcinoma (HCC) remains a major global health challenge with high mortality, particularly in patients with intermediate-stage disease, where curative options are limited. Transarterial chemoembolization (TACE) is the mainstay of treatment in such cases, offering locoregional tumor control by combining targeted chemotherapy and embolization. This review explores current strategies to optimize TACE, including advancements in drug delivery systems such as drug-eluting beads and balloon-occluded techniques, and highlights the importance of patient selection based on Barcelona Clinic Liver Cancer (BCLC) staging, liver function, and performance status. Emerging combination therapies, such as TACE with systemic agents like sorafenib, lenvatinib, and apatinib, or immunotherapies like atezolizumab-bevacizumab, show promise in improving progression-free and overall survival. Additionally, TACE plays a critical role in bridging and downstaging patients for liver transplantation. Future directions focus on integrating radiomics, artificial intelligence, and inflammatory biomarkers to enhance treatment personalization and predict therapeutic response. Despite its established role, TACE is not without risks, including post-embolization syndrome and organ-specific ischemic complications. Continued research is essential to refine selection criteria, minimize adverse effects, and validate innovative approaches, ultimately improving outcomes for HCC patients across diverse clinical scenarios.

Для цитирования: Dolphin Jeraun, Zubillaga Juan, Jamal Qazi Muhammad, Edakkattu Afrah Fathima Karimbanakkal, Balakrishnan Bhavana, Sapkota Aarati, Naimat Anum, Nyein Aye, Okorie Confidence Obianuju, Mahmood Ahmad, Dev Aabind S. Optimizing Transarterial Chemoembolization in Hepatocellular Carcinoma: Current Strategies, Innovations, and Future Directions.. Cureus. 2025. DOI: 10.7759/cureus.95128.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.